Bioinformatics Market

Global Bioinformatics Market was valued at USD 20.12 Billion in 2021, growing at a CAGR of 15.14% during the forecast period from 2023 to 2028 to reach USD 46.88 Billion by 2028.

The Bioinformatics market is witnessing positive growth owing to the rising demand for both nucleic acid and protein sequencing, rising need for integrated data, technological innovation in product development, thereby contributing to the growth of the Bioinformatics market during the forecast period from 2023-2028.

Some of the key market players operating in the Bioinformatics market include Agilent Technologies, Biomax Informatics AG, DNANEXUS, INC., Thermo Fisher Scientific, Inc., Eurofins Scientific, QIAGEN N.V., Illumina Inc., NeoGenomics Laboratories, Rosalind Inc., Perkin Elmer, Inc., GENEWIZ, BGI Corporation, Waters Corporation, DNASTAR, Fios Genomics, Partek Incorporated, SOPHiA Genetics, Source Bioscience, Biomax Informatics AG, Seven Bridges Genomics Inc., and others.

DelveInsight’s “Bioinformatics Market Insight & Forecast” report will offer an in-depth understanding of the Bioinformatics market, further benefiting the competitors or stakeholders operating in the Bioinformatics arena.

Bioinformatics Overview

Bioinformatics is an interdisciplinary field that develops methods and software tools for understanding biological data, in particular when the data sets are large and complex. 

Bioinformatics Market Insights

Among all the regions, North America is expected to account for the largest share of the Global Bioinformatics market. Growing demand for advanced technologies in Bioinformatics, rising prevalence of the COVID-19 pandemic, higher requirement of personalized medicine in this region, and the launch of new and innovative bioinformatics software will boost the growth of the bioinformatics market. 

For instance, the rising cases of COVID 19 will lead to an increase in the growth of the bioinformatics market. For instance, as per the Centers for Disease Control and Prevention 2022, in the year 2021, the United States had reported 79 million COVID-19 cases since the pandemic began. Also, the deaths that were related to COVID-19 in the United States had topped 9,60,000.

Also, the launch of various new bioinformatics platforms in the United States will aid in providing better and faster next-generation sequencing test results. For instance, on March 07, 2022, Arup had launched the new bioinformatics platform, Rio, a new world-class bioinformatics pipeline and analytics platform. It amplifies the ARUP’s existing cloud computing capabilities to move data more efficiently and with greater accuracy to speed targeted test results to clinicians for analysis and improved medical decision-making for patients.

Therefore, all the above-mentioned factors are anticipated to propel the Bioinformatics market in the United States region. 

To read more about why North America is leading the market growth in the Bioinformatics market, get a snapshot of the Bioinformatics market report.

Bioinformatics Market Dynamics

The Bioinformatics market is witnessing a growth in product demand owing to various reasons. The rising demand for both nucleic acid and protein sequencing is the key driving factor for the Bioinformatics market. Protein sequencing is the practical process of determining the amino acid sequence of all or parts of a protein or peptide. Protein sequencing is the process that helps in the identification of protein or characterizing the post-translational modifications. DNA sequencing is the process for determining the nucleic acid sequence-the order of nucleotides in the DNA. It includes different methods or technology for determining the order of the four bases, such as adenine, guanine, cytosine, and thymine. The introduction of various tools such as DNAnexus Apollo and DNAnexus Titan by DNANEXUS INC. helps in accelerating the process of precision drug discovery. 

Furthermore, the bioinformatics platform also provides precision drug discovery programs by empowering the scientists and clinicians for exploring and analyzing both omics and clinical data together, in a single environment based on a robust, scalable, cloud platform. These platforms will further contribute to the industry’s growth. Furthermore, the need for disease management, prevention, and treatment coupled with developments in bioinformatics augments the market growth. Most importantly, the current COVID-19 pandemic and demand for newer treatments and vaccines will also increase the demand for nucleic acid and protein sequencing. 

Therefore, due to the rising demand for nucleic acid and protein sequencing, there will be an increase in the demand for bioinformatics, thereby fueling the market growth for Bioinformatics. However, higher costs associated with the bioinformatics software and services and a dearth of skilled professionals may be certain limiting factors to the Bioinformatics market growth. 

The unprecedented COVID-19 outbreak had a profound impact on the market for Bioinformatics. Most importantly, the current COVID-19 pandemic and the rising demand for newer treatments and vaccines help in providing better opportunities for the global bioinformatics market. Bioinformatics has always had huge potential when it comes to providing essential support to several areas of scientific research. One of the major focus areas for every country during COVID-19 has been to study and halt the progress of the virus. 

Recent Breakthroughs in Bioinformatics Market:

• On March 02, 2022, BISC Global, a Bioinformatics, Biostatistics, and ML/AI consulting company is partnering with cropSeq bioinformatics, a company specialized in AgriGenomics consulting, to address the most pressing challenges in data-driven agriculture and plant research.
• In February 2022, Bruker Corporation announced its TIMS DIA-NN software for the high-throughput, deep and unbiased 4D proteomics workflow. 

Key Players Proactively Working In the Bioinformatics Market

Key Bioinformatics companies involved in manufacturing and production are making significant growth in the advancement of these devices. To boost their market position, they also engage in mergers and acquisitions. Some of the key Bioinformatics companies operating actively in the Bioinformatics market include Agilent Technologies, Biomax Informatics AG, DNANEXUS, INC., Thermo Fisher Scientific, Inc., Eurofins Scientific, QIAGEN N.V., Illumina Inc., NeoGenomics Laboratories, Rosalind Inc., Perkin Elmer, Inc., GENEWIZ, BGI Corporation, Waters Corporation, DNASTAR, Fios Genomics, Partek Incorporated, SOPHiA Genetics, Source Bioscience, Biomax Informatics AG, Seven Bridges Genomics Inc., and others.

Scope of the Bioinformatics Market Report:

• Geography Covered: Global
• Study Period: 2022-2027
• Key Companies: Agilent Technologies, Biomax Informatics AG, DNANEXUS, INC., Thermo Fisher Scientific, Inc., Eurofins Scientific, QIAGEN N.V., Illumina Inc., NeoGenomics Laboratories, Rosalind Inc., Perkin Elmer, Inc., GENEWIZ, BGI Corporation, Waters Corporation, DNASTAR, Fios Genomics, Partek Incorporated, SOPHiA Genetics, Source Bioscience, Biomax Informatics AG, Seven Bridges Genomics Inc., and others.
• Market Segmentation by Type: Bioinformatics Products, Bioinformatics Services
• Market Segmentation By Product- Knowledge Management Tools, Bioinformatics Platforms
• Market Segmentation by Application- Genomics, Proteomics, Transcriptomics, Others
• Market Segmentation by Sector: Medical Bioinformatics, Animal Bioinformatics, Agriculture Bioinformatics, Others
• Market Segmentation by Geography: North America, Europe, Asia-Pacific, Rest of the World (Middle East, Africa, and South America)
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Table of Contents 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services